U.S. FDA’s Center for Drug Evaluation and Research (CDER) will be presenting the CDER Forum for International Drug Regulatory Authorities (CDER Forum) September 8-12, 2014. The 17th CDER Forum will discuss the identification, evaluation, and monitoring of adverse events in three key areas of the drug life cycle: during clinical trials, FDA application review, and postmarket monitoring and analysis. More details will be provided a recently approved drug product in future announcements. This revamped CDER Forum will also provide opportunities to learn from one another and promote discussion of common areas of concern.
Information on location and accommodations for the meeting will be provided in the near future. Interested participants should register as described below and begin their visa process. There is no registration fee for the program, however all attendees are responsible for their own travel and hotel expenses.
Please direct any questions to the CDER Forum mailbox: CDERForum@fda.hhs.gov.
Registration information and requests should be sent to CDERForum@fda.hhs.gov. As a reminder, the CDER Forum is intended for international drug regulatory authorities, and registration from nondrug regulatory authorities will not be honored.
Please include the following information about the proposed attendee:
- Country and Drug Regulatory Authority
- Topic/Area of Interest